Drooid Logo
Back to story perspectives

Full Breakdown

Senate Democrats Question HHS Secretary Robert F. Kennedy Jr.’s Potential Gain from Merck Gardasil Settlement

7/30/2026, 2:06:14 AM

Core Issue: Letter Raises Conflict-of-Interest Concerns

A group of Senate Democrats sent a letter to Health and Human Services Secretary Robert F. Kennedy Jr. asking whether his family could profit from Merck & Co.’s recent $50 million settlement over its Gardasil vaccine. The senators—Elizabeth Warren of Massachusetts, Angela Alsobrooks of Maryland, Richard Blumenthal of Connecticut, and Andy Kim of New Jersey—highlighted that Kennedy, a former vaccine-injury attorney, was listed as an attorney of record in several Gardasil cases. They argued that the settlement created a significant conflict of interest given Kennedy’s authority over federal vaccine policy.

Background: Kennedy’s Legal Ties and the Merck Settlement

During his confirmation hearing, filings with the U.S. Office of Government Ethics disclosed that Kennedy could receive fees from settlements tied to cases he referred to the law firm Wisner Baum. He initially indicated he would retain a 10 percent fee from any Gardasil-related settlements, with the remainder to be diverted to his “non-dependent adult son,” Conor Kennedy, who works at Wisner Baum. The Merck settlement, reached with the company over Gardasil litigation, totals $50 million.

Official Statements & Responses

The senators’ letter asked for clarification on the total legal fees paid and whether Conor Kennedy would receive any portion of the settlement. Kennedy later amended his plan, stating he would divest his interests in the Gardasil cases to Wisner Baum, with any proceeds directed to his son. Brent Wisner, managing partner of Wisner Baum, responded by email that “at no time” will Kennedy or his son receive fees from the Gardasil settlement. An HHS spokesperson did not immediately comment on the inquiry.

Data & Statistics: Settlement Figures and Potential Earnings

  • Merck & Co. settlement amount: $50 million.
  • Kennedy’s originally disclosed fee: 10 percent of settlement proceeds.

The inquiry underscores ongoing scrutiny of Kennedy’s transition from vaccine-injury litigation to overseeing national vaccine policy.